A new report by Canada's drug price regulator warns that new medicines are becoming increasingly expensive. Almost half of the new drugs coming on the market in 2016 and 2017 were "orphan" drugs aimed at treating rare diseases, with the average cost per patient approaching $1 million a year.
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.